Global Flu Vaccine Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

Publisher Name :
Date: 16-Jan-2020
No. of pages: 103

Summary

Market Overview

The global Flu Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Flu Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation

Flu Vaccine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Flu Vaccine market has been segmented into Split Influenza Vaccine, Pandemic Influenza Vaccine, Subunit Influenza Vaccine, Quadrivalent Influenza Vaccine, etc.

By Application, Flu Vaccine has been segmented into For Children (6 months to 3 years), For Adults and Children over 3 years, etc.

Regions and Countries Level Analysis

Regional analysis is another highly comprehensive part of the research and analysis study of the global Flu Vaccine market presented in the report. This section sheds light on the sales growth of different regional and country-level Flu Vaccine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Flu Vaccine market.

The report offers in-depth assessment of the growth and other aspects of the Flu Vaccine market in important countries (regions), including United States, Canada, Mexico, Germany, France, United Kingdom, Russia, Italy, China, Japan, Korea, India, Southeast Asia, Australia, Brazil and Saudi Arabia, etc. It also throws light on the progress of key regional Flu Vaccine markets such as North America, Europe, Asia-Pacific, South America and Middle East & Africa.

Competitive Landscape and Flu Vaccine Market Share Analysis

Flu Vaccine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Flu Vaccine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Flu Vaccine sales, revenue and market share for each player covered in this report.

The major players covered in Flu Vaccine are: Hualan Bio, Changsheng Biological, SANOFI, CCBIO, SINOVAC, Aleph Biomedical, GSK, ZYAK, Adimmune, SIOBP, Aimei Hissen, Tianyuan Bio-pharma(Novartis), Simcere Vaxtec, etc. Among other players domestic and global, Flu Vaccine market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Flu Vaccine product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Flu Vaccine, with price, sales, revenue and global market share of Flu Vaccine in 2018 and 2019.

Chapter 3, the Flu Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Flu Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.

Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.

Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.

Chapter 12, Flu Vaccine market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.

Chapter 13, 14 and 15, to describe Flu Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Global Flu Vaccine Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

Table of Contents

1 Market Overview
1.1 Flu Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Flu Vaccine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Split Influenza Vaccine
1.2.3 Pandemic Influenza Vaccine
1.2.4 Subunit Influenza Vaccine
1.2.5 Quadrivalent Influenza Vaccine
1.3 Market Analysis by Application
1.3.1 Overview: Global Flu Vaccine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 For Children (6 months to 3 years)
1.3.3 For Adults and Children over 3 years
1.4 Overview of Global Flu Vaccine Market
1.4.1 Global Flu Vaccine Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Hualan Bio
2.1.1 Hualan Bio Details
2.1.2 Hualan Bio Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Hualan Bio SWOT Analysis
2.1.4 Hualan Bio Product and Services
2.1.5 Hualan Bio Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Changsheng Biological
2.2.1 Changsheng Biological Details
2.2.2 Changsheng Biological Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Changsheng Biological SWOT Analysis
2.2.4 Changsheng Biological Product and Services
2.2.5 Changsheng Biological Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 SANOFI
2.3.1 SANOFI Details
2.3.2 SANOFI Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 SANOFI SWOT Analysis
2.3.4 SANOFI Product and Services
2.3.5 SANOFI Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 CCBIO
2.4.1 CCBIO Details
2.4.2 CCBIO Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 CCBIO SWOT Analysis
2.4.4 CCBIO Product and Services
2.4.5 CCBIO Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 SINOVAC
2.5.1 SINOVAC Details
2.5.2 SINOVAC Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 SINOVAC SWOT Analysis
2.5.4 SINOVAC Product and Services
2.5.5 SINOVAC Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Aleph Biomedical
2.6.1 Aleph Biomedical Details
2.6.2 Aleph Biomedical Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Aleph Biomedical SWOT Analysis
2.6.4 Aleph Biomedical Product and Services
2.6.5 Aleph Biomedical Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 GSK
2.7.1 GSK Details
2.7.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 GSK SWOT Analysis
2.7.4 GSK Product and Services
2.7.5 GSK Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 ZYAK
2.8.1 ZYAK Details
2.8.2 ZYAK Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 ZYAK SWOT Analysis
2.8.4 ZYAK Product and Services
2.8.5 ZYAK Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Adimmune
2.9.1 Adimmune Details
2.9.2 Adimmune Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Adimmune SWOT Analysis
2.9.4 Adimmune Product and Services
2.9.5 Adimmune Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 SIOBP
2.10.1 SIOBP Details
2.10.2 SIOBP Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 SIOBP SWOT Analysis
2.10.4 SIOBP Product and Services
2.10.5 SIOBP Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Aimei Hissen
2.11.1 Aimei Hissen Details
2.11.2 Aimei Hissen Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Aimei Hissen SWOT Analysis
2.11.4 Aimei Hissen Product and Services
2.11.5 Aimei Hissen Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Tianyuan Bio-pharma(Novartis)
2.12.1 Tianyuan Bio-pharma(Novartis) Details
2.12.2 Tianyuan Bio-pharma(Novartis) Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Tianyuan Bio-pharma(Novartis) SWOT Analysis
2.12.4 Tianyuan Bio-pharma(Novartis) Product and Services
2.12.5 Tianyuan Bio-pharma(Novartis) Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Simcere Vaxtec
2.13.1 Simcere Vaxtec Details
2.13.2 Simcere Vaxtec Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Simcere Vaxtec SWOT Analysis
2.13.4 Simcere Vaxtec Product and Services
2.13.5 Simcere Vaxtec Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Flu Vaccine Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Flu Vaccine Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Flu Vaccine Manufacturer Market Share in 2019
3.3.2 Top 6 Flu Vaccine Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Flu Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global Flu Vaccine Sales and Market Share by Regions (2015-2020)
4.1.2 Global Flu Vaccine Revenue and Market Share by Regions (2015-2020)
4.2 North America Flu Vaccine Sales and Growth Rate (2015-2020)
4.3 Europe Flu Vaccine Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Flu Vaccine Sales and Growth Rate (2015-2020)
4.5 South America Flu Vaccine Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Flu Vaccine Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Flu Vaccine Sales, Revenue and Market Share by Country
5.1.1 North America Flu Vaccine Sales and Market Share by Country (2015-2020)
5.1.2 North America Flu Vaccine Revenue and Market Share by Country (2015-2020)
5.2 United States Flu Vaccine Sales and Growth Rate (2015-2020)
5.3 Canada Flu Vaccine Sales and Growth Rate (2015-2020)
5.4 Mexico Flu Vaccine Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Flu Vaccine Sales, Revenue and Market Share by Country
6.1.1 Europe Flu Vaccine Sales and Market Share by Country (2015-2020)
6.1.2 Europe Flu Vaccine Revenue and Market Share by Country (2015-2020)
6.2 Germany Flu Vaccine Sales and Growth Rate (2015-2020)
6.3 UK Flu Vaccine Sales and Growth Rate (2015-2020)
6.4 France Flu Vaccine Sales and Growth Rate (2015-2020)
6.5 Russia Flu Vaccine Sales and Growth Rate (2015-2020)
6.6 Italy Flu Vaccine Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Flu Vaccine Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Flu Vaccine Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Flu Vaccine Revenue and Market Share by Regions (2015-2020)
7.2 China Flu Vaccine Sales and Growth Rate (2015-2020)
7.3 Japan Flu Vaccine Sales and Growth Rate (2015-2020)
7.4 Korea Flu Vaccine Sales and Growth Rate (2015-2020)
7.5 India Flu Vaccine Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Flu Vaccine Sales and Growth Rate (2015-2020)
7.7 Australia Flu Vaccine Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Flu Vaccine Sales, Revenue and Market Share by Country
8.1.1 South America Flu Vaccine Sales and Market Share by Country (2015-2020)
8.1.2 South America Flu Vaccine Revenue and Market Share by Country (2015-2020)
8.2 Brazil Flu Vaccine Sales and Growth Rate (2015-2020)
8.3 Argentina Flu Vaccine Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Flu Vaccine Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Flu Vaccine Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Flu Vaccine Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Flu Vaccine Sales and Growth Rate (2015-2020)
9.3 Turkey Flu Vaccine Sales and Growth Rate (2015-2020)
9.4 Egypt Flu Vaccine Sales and Growth Rate (2015-2020)
9.5 South Africa Flu Vaccine Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Flu Vaccine Sales and Market Share by Type (2015-2020)
10.2 Global Flu Vaccine Revenue and Market Share by Type (2015-2020)
10.3 Global Flu Vaccine Price by Type (2015-2020)
11 Global Flu Vaccine Market Segment by Application
11.1 Global Flu Vaccine Sales Market Share by Application (2015-2020)
11.2 Global Flu Vaccine Revenue Market Share by Application (2015-2020)
11.3 Global Flu Vaccine Price by Application (2015-2020)
12 Market Forecast
12.1 Global Flu Vaccine Sales, Revenue and Growth Rate (2021-2025)
12.2 Flu Vaccine Market Forecast by Regions (2021-2025)
12.2.1 North America Flu Vaccine Market Forecast (2021-2025)
12.2.2 Europe Flu Vaccine Market Forecast (2021-2025)
12.2.3 Asia-Pacific Flu Vaccine Market Forecast (2021-2025)
12.2.4 South America Flu Vaccine Market Forecast (2021-2025)
12.2.5 Middle East & Africa Flu Vaccine Market Forecast (2021-2025)
12.3 Flu Vaccine Market Forecast by Type (2021-2025)
12.3.1 Global Flu Vaccine Sales Forecast by Type (2021-2025)
12.3.2 Global Flu Vaccine Market Share Forecast by Type (2021-2025)
12.4 Flu Vaccine Market Forecast by Application (2021-2025)
12.4.1 Global Flu Vaccine Sales Forecast by Application (2021-2025)
12.4.2 Global Flu Vaccine Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables

Table 1. Global Flu Vaccine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Flu Vaccine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Flu Vaccine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Hualan Bio Basic Information, Manufacturing Base and Competitors
Table 8. Hualan Bio Flu Vaccine Major Business
Table 9. Hualan Bio Flu Vaccine Total Revenue (USD Million) (2017-2018)
Table 10. Hualan Bio SWOT Analysis
Table 11. Hualan Bio Flu Vaccine Product and Services
Table 12. Hualan Bio Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Changsheng Biological Basic Information, Manufacturing Base and Competitors
Table 14. Changsheng Biological Flu Vaccine Major Business
Table 15. Changsheng Biological Flu Vaccine Total Revenue (USD Million) (2017-2018)
Table 16. Changsheng Biological SWOT Analysis
Table 17. Changsheng Biological Flu Vaccine Product and Services
Table 18. Changsheng Biological Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. SANOFI Basic Information, Manufacturing Base and Competitors
Table 20. SANOFI Flu Vaccine Major Business
Table 21. SANOFI Flu Vaccine Total Revenue (USD Million) (2017-2018)
Table 22. SANOFI SWOT Analysis
Table 23. SANOFI Flu Vaccine Product and Services
Table 24. SANOFI Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. CCBIO Basic Information, Manufacturing Base and Competitors
Table 26. CCBIO Flu Vaccine Major Business
Table 27. CCBIO Flu Vaccine Total Revenue (USD Million) (2017-2018)
Table 28. CCBIO SWOT Analysis
Table 29. CCBIO Flu Vaccine Product and Services
Table 30. CCBIO Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. SINOVAC Basic Information, Manufacturing Base and Competitors
Table 32. SINOVAC Flu Vaccine Major Business
Table 33. SINOVAC Flu Vaccine Total Revenue (USD Million) (2017-2018)
Table 34. SINOVAC SWOT Analysis
Table 35. SINOVAC Flu Vaccine Product and Services
Table 36. SINOVAC Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Aleph Biomedical Basic Information, Manufacturing Base and Competitors
Table 38. Aleph Biomedical Flu Vaccine Major Business
Table 39. Aleph Biomedical Flu Vaccine Total Revenue (USD Million) (2017-2018)
Table 40. Aleph Biomedical SWOT Analysis
Table 41. Aleph Biomedical Flu Vaccine Product and Services
Table 42. Aleph Biomedical Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. GSK Basic Information, Manufacturing Base and Competitors
Table 44. GSK Flu Vaccine Major Business
Table 45. GSK Flu Vaccine Total Revenue (USD Million) (2017-2018)
Table 46. GSK SWOT Analysis
Table 47. GSK Flu Vaccine Product and Services
Table 48. GSK Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. ZYAK Basic Information, Manufacturing Base and Competitors
Table 50. ZYAK Flu Vaccine Major Business
Table 51. ZYAK Flu Vaccine Total Revenue (USD Million) (2017-2018)
Table 52. ZYAK SWOT Analysis
Table 53. ZYAK Flu Vaccine Product and Services
Table 54. ZYAK Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Adimmune Basic Information, Manufacturing Base and Competitors
Table 56. Adimmune Flu Vaccine Major Business
Table 57. Adimmune Flu Vaccine Total Revenue (USD Million) (2017-2018)
Table 58. Adimmune SWOT Analysis
Table 59. Adimmune Flu Vaccine Product and Services
Table 60. Adimmune Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. SIOBP Basic Information, Manufacturing Base and Competitors
Table 62. SIOBP Flu Vaccine Major Business
Table 63. SIOBP Flu Vaccine Total Revenue (USD Million) (2017-2018)
Table 64. SIOBP SWOT Analysis
Table 65. SIOBP Flu Vaccine Product and Services
Table 66. SIOBP Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Aimei Hissen Basic Information, Manufacturing Base and Competitors
Table 68. Aimei Hissen Flu Vaccine Major Business
Table 69. Aimei Hissen Flu Vaccine Total Revenue (USD Million) (2017-2018)
Table 70. Aimei Hissen SWOT Analysis
Table 71. Aimei Hissen Flu Vaccine Product and Services
Table 72. Aimei Hissen Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Tianyuan Bio-pharma(Novartis) Basic Information, Manufacturing Base and Competitors
Table 74. Tianyuan Bio-pharma(Novartis) Flu Vaccine Major Business
Table 75. Tianyuan Bio-pharma(Novartis) Flu Vaccine Total Revenue (USD Million) (2017-2018)
Table 76. Tianyuan Bio-pharma(Novartis) SWOT Analysis
Table 77. Tianyuan Bio-pharma(Novartis) Flu Vaccine Product and Services
Table 78. Tianyuan Bio-pharma(Novartis) Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Simcere Vaxtec Basic Information, Manufacturing Base and Competitors
Table 80. Simcere Vaxtec Flu Vaccine Major Business
Table 81. Simcere Vaxtec Flu Vaccine Total Revenue (USD Million) (2017-2018)
Table 82. Simcere Vaxtec SWOT Analysis
Table 83. Simcere Vaxtec Flu Vaccine Product and Services
Table 84. Simcere Vaxtec Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Global Flu Vaccine Sales by Manufacturer (2018-2019) (K Doses)
Table 86. Global Flu Vaccine Revenue by Manufacturer (2018-2019) (USD Million)
Table 87. Global Flu Vaccine Sales by Regions (2015-2020) (K Doses)
Table 88. Global Flu Vaccine Sales Market Share by Regions (2015-2020)
Table 89. Global Flu Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 90. North America Flu Vaccine Sales by Countries (2015-2020) (K Doses)
Table 91. North America Flu Vaccine Sales Market Share by Countries (2015-2020)
Table 92. North America Flu Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 93. North America Flu Vaccine Revenue Market Share by Countries (2015-2020)
Table 94. Europe Flu Vaccine Sales by Countries (2015-2020) (K Doses)
Table 95. Europe Flu Vaccine Sales Market Share by Countries (2015-2020)
Table 96. Europe Flu Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 97. Asia-Pacific Flu Vaccine Sales by Regions (2015-2020) (K Doses)
Table 98. Asia-Pacific Flu Vaccine Sales Market Share by Regions (2015-2020)
Table 99. Asia-Pacific Flu Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 100. South America Flu Vaccine Sales by Countries (2015-2020) (K Doses)
Table 101. South America Flu Vaccine Sales Market Share by Countries (2015-2020)
Table 102. South America Flu Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 103. South America Flu Vaccine Revenue Market Share by Countries (2015-2020)
Table 104. Middle East & Africa Flu Vaccine Sales by Countries (2015-2020) (K Doses)
Table 105. Middle East & Africa Flu Vaccine Sales Market Share by Countries (2015-2020)
Table 106. Middle East & Africa Flu Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 107. Middle East & Africa Flu Vaccine Revenue Market Share by Countries (2015-2020)
Table 108. Global Flu Vaccine Sales by Type (2015-2020) (K Doses)
Table 109. Global Flu Vaccine Sales Share by Type (2015-2020)
Table 110. Global Flu Vaccine Revenue by Type (2015-2020) (USD Million)
Table 111. Global Flu Vaccine Revenue Share by Type (2015-2020)
Table 112. Global Flu Vaccine Sales by Application (2015-2020) (K Doses)
Table 113. Global Flu Vaccine Sales Share by Application (2015-2020)
Table 114. Global Flu Vaccine Sales Forecast by Regions (2021-2025) (K Doses)
Table 115. Global Flu Vaccine Market Share Forecast by Regions (2021-2025)
Table 116. Global Flu Vaccine Sales Forecast by Type (2021-2025) (K Doses)
Table 117. Global Flu Vaccine Market Share Forecast by Type (2021-2025)
Table 118. Global Flu Vaccine Sales Forecast by Application (2021-2025)
Table 119. Global Flu Vaccine Market Share Forecast by Application (2021-2025)
Table 120. Direct Channel Pros & Cons
Table 121. Indirect Channel Pros & Cons
Table 122. Distributors/Traders/ Dealers List

List of Figures

Figure 1. Flu Vaccine Picture
Figure 2. Global Sales Market Share of Flu Vaccine by Type in 2019
Figure 3. Split Influenza Vaccine Picture
Figure 4. Pandemic Influenza Vaccine Picture
Figure 5. Subunit Influenza Vaccine Picture
Figure 6. Quadrivalent Influenza Vaccine Picture
Figure 7. Flu Vaccine Sales Market Share by Application in 2018
Figure 8. For Children (6 months to 3 years) Picture
Figure 9. For Adults and Children over 3 years Picture
Figure 10. Global Flu Vaccine Market Status and Outlook (2015-2025) (USD Million)
Figure 11. United States Flu Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Canada Flu Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Mexico Flu Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Germany Flu Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 15. France Flu Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 16. UK Flu Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Russia Flu Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Italy Flu Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 19. China Flu Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Japan Flu Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Korea Flu Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 22. India Flu Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Southeast Asia Flu Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Australia Flu Vaccine Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 25. Brazil Flu Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Egypt Flu Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Saudi Arabia Flu Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 28. South Africa Flu Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Turkey Flu Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Global Flu Vaccine Sales Market Share by Manufacturer in 2019
Figure 31. Global Flu Vaccine Revenue Market Share by Manufacturer in 2019
Figure 32. Top 3 Flu Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 33. Top 6 Flu Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 34. Key Manufacturer Market Share Trend
Figure 35. Global Flu Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 36. Global Flu Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 37. Global Flu Vaccine Revenue Market Share by Regions (2015-2020)
Figure 38. Global Flu Vaccine Revenue Market Share by Regions in 2018
Figure 39. North America Flu Vaccine Sales and Growth Rate (2015-2020)
Figure 40. Europe Flu Vaccine Sales and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Flu Vaccine Sales and Growth Rate (2015-2020)
Figure 42. South America Flu Vaccine Sales and Growth Rate (2015-2020)
Figure 43. Middle East & Africa Flu Vaccine Sales and Growth Rate (2015-2020)
Figure 44. North America Flu Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 45. North America Flu Vaccine Sales Market Share by Countries (2015-2020)
Figure 46. North America Flu Vaccine Sales Market Share by Countries in 2018
Figure 47. North America Flu Vaccine Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 48. North America Flu Vaccine Revenue Market Share by Countries in 2018
Figure 49. United States Flu Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 50. Canada Flu Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 51. Mexico Flu Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 52. Europe Flu Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 53. Europe Flu Vaccine Revenue Market Share by Countries (2015-2020)
Figure 54. Europe Flu Vaccine Revenue Market Share by Countries in 2019
Figure 55. Germany Flu Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 56. UK Flu Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 57. France Flu Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 58. Russia Flu Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 59. Italy Flu Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 60. Asia-Pacific Flu Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 61. Asia-Pacific Flu Vaccine Sales Market Share by Regions 2019
Figure 62. Asia-Pacific Flu Vaccine Revenue Market Share by Regions 2019
Figure 63. China Flu Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 64. Japan Flu Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 65. Korea Flu Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 66. India Flu Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 67. Southeast Asia Flu Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 68. South America Flu Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 69. South America Flu Vaccine Sales Market Share by Countries in 2019
Figure 70. South America Flu Vaccine Revenue Market Share by Countries in 2019
Figure 71. Brazil Flu Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 72. Argentina Flu Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 73. Middle East and Africa Flu Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. Middle East and Africa Flu Vaccine Sales Market Share by Countries in 2019
Figure 75. Middle East and Africa Flu Vaccine Revenue Market Share by Countries (2015-2020)
Figure 76. Middle East and Africa Flu Vaccine Revenue Market Share by Countries in 2019
Figure 77. Saudi Arabia Flu Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 78. Egypt Flu Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 79. Turkey Flu Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 80. South Africa Flu Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 81. Global Flu Vaccine Sales and Growth Rate (2021-2025) (K Doses)
Figure 82. Global Flu Vaccine Revenue and Growth Rate (2021-2025) (USD Million)
Figure 83. North America Sales Flu Vaccine Market Forecast (2021-2025) (K Doses)
Figure 84. Europe Sales Flu Vaccine Market Forecast (2021-2025) (K Doses)
Figure 85. Asia-Pacific Sales Flu Vaccine Market Forecast (2021-2025) (K Doses)
Figure 86. South America Sales Flu Vaccine Market Forecast (2021-2025) (K Doses)
Figure 87. Middle East & Africa Sales Flu Vaccine Market Forecast (2021-2025) (K Doses)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel
  • Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87
    The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......
  • Global Esomeprazole Magnesium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74
    The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......
  • Global Combination Therapy Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......
  • Global Axitinib Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68
    The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......
  • Global Lyme Disease Vaccine Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70
    The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......
  • Global Transdermal Absorption Patch Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......
  • Global Ketoprofen Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......
  • Global Methyl Salicylate Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82
    The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......
  • Global Diclofenac Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs